News Focus
News Focus
Followers 229
Posts 34993
Boards Moderated 1
Alias Born 11/19/2003

Re: None

Wednesday, 03/12/2014 1:26:04 PM

Wednesday, March 12, 2014 1:26:04 PM

Post# of 5
Silence Therapeutics plc Rating Reiterated by Canaccord Genuity (SLN)
Posted by Jim Brewer on Feb 27th, 2014 // No Comments

Silence Therapeutics plc (LON:SLN)‘s stock had its “buy” rating restated by stock analysts at Canaccord Genuity in a report issued on Thursday, Analyst Ratings News reports. They currently have a GBX 496 ($8.25) target price on the stock. Canaccord Genuity’s price objective would indicate a potential upside of 32.27% from the company’s current price.
Separately, analysts at N+1 Singer reiterated a “corporate” rating on shares of Silence Therapeutics plc in a research note on Thursday.

Silence Therapeutics plc (LON:SLN) opened at 375.00 on Thursday. Silence Therapeutics plc has a 52-week low of GBX 155.00 and a 52-week high of GBX 388.75. The stock’s 50-day moving average is GBX 315.6 and its 200-day moving average is GBX 256.6.
Silence Therapeutics plc (LON:SLN) is a biotechnology research and development company.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SLNCF News